Free tool
Drug Trial Radar: Pain and anesthesia
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Active, not recruiting, industry sponsors, Pain and anesthesia, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed261
2 trials
Showing 1 to 2, recently updated first.
- A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved RemissionPivotal-lookingActive, not recruiting
Novartis PharmaceuticalsNovartis (NVS)
NCT05622708 · 240 participants · Start Mar 28, 2023 · Primary completion Feb 8, 2028
Drug: Secukinumab; Placebo and 1 more · For: Non-radiographic Axial Spondyloarthritis
Sites: Genk, Belgium; Bruges, Belgium; Ghent, Belgium · 61 sites in all
- A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.Active, not recruiting
Heron TherapeuticsIndustry
NCT05109312 · 90 participants (planned) · Start Oct 12, 2021 · Primary completion Jun 2024
Drug: Bupivacaine Hydrochloride; Bupivacaine Hydrochloride and 3 more · For: Analgesia
Sites: Little Rock, Arkansas; Sarasota, Florida; Tulsa, Oklahoma · 7 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.